SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    B. Dunkel, Platelet transfusion in thrombocytopenic horses, Equine Veterinary Education, 2013, 25, 7
  2. 2
    David J. Kuter, Consultative Hemostasis and Thrombosis, 2013,

    CrossRef

  3. 3
    Bryan D. Hux, Linda G. Martin, Platelet transfusions: treatment options for hemorrhage secondary to thrombocytopenia, Journal of Veterinary Emergency and Critical Care, 2012, 22, 1
  4. 4
    Torunn O. Apelseth, Tor Hervig, Øystein Bruserud, Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia, Blood Reviews, 2011, 25, 3, 113

    CrossRef

  5. 5
    O. Erhabor, T.C. Adias, From whole blood to component therapy: The economic, supply/demand need for implementation of component therapy in sub-Saharan Africa, Transfusion Clinique et Biologique, 2011, 18, 5-6, 516

    CrossRef

  6. 6
    Lise J. Estcourt, S. J. Stanworth, M. F. Murphy, Platelet transfusions for patients with haematological malignancies: who needs them?, British Journal of Haematology, 2011, 154, 4
  7. 7
    Simon J. Stanworth, Claire Dyer, Louise Choo, Lekha Bakrania, Adrian Copplestone, Charlotte Llewelyn, Derek Norfolk, Gillian Powter, Tim Littlewood, Erica M. Wood, Mike F. Murphy, Do All Patients With Hematologic Malignancies and Severe Thrombocytopenia Need Prophylactic Platelet Transfusions?, Transfusion Medicine Reviews, 2010, 24, 3, 163

    CrossRef

  8. 8
    Sherrill J. Slichter, Richard M. Kaufman, Susan F. Assmann, Jeffrey McCullough, Darrell J. Triulzi, Ronald G. Strauss, Terry B. Gernsheimer, Paul M. Ness, Mark E. Brecher, Cassandra D. Josephson, Barbara A. Konkle, Robert D. Woodson, Thomas L. Ortel, Christopher D. Hillyer, Donna L. Skerrett, Keith R. McCrae, Steven R. Sloan, Lynne Uhl, James N. George, Victor M. Aquino, Catherine S. Manno, Janice G. McFarland, John R. Hess, Cindy Leissinger, Suzanne Granger, Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage, New England Journal of Medicine, 2010, 362, 7, 600

    CrossRef

  9. 9
    Pieter F. van der Meer, Bert Tomson, Anneke Brand, In vivo tracking of transfused platelets for recovery and survival studies: An appraisal of labeling methods, Transfusion and Apheresis Science, 2010, 42, 1, 53

    CrossRef

  10. 10
    Joan Cid, Miguel Lozano, Platelet dose for prophylactic platelet transfusions, Expert Review of Hematology, 2010, 3, 4, 397

    CrossRef

  11. 11
    Seth Eisenberg, Refractory Response to Platelet Transfusion Therapy, Journal of Infusion Nursing, 2010, 33, 2, 89

    CrossRef

  12. 12
    Matt Emery, Rosen's Emergency Medicine – Concepts and Clinical Practice, 2010,

    CrossRef

  13. You have free access to this content13
    Richard J. Cook, Nancy M. Heddle, Measuring and reporting the effect of an intervention: relative measures, Transfusion, 2009, 49, 1
  14. 14
    Richard M. Kaufman, Platelet ABO matters, Transfusion, 2009, 49, 1
  15. 15
    Elisabeth Maurer-Spurej, Audrey Labrie, Cheryl Pittendreigh, Kate Chipperfield, Clayton Smith, Nancy Heddle, Yang Liu, Qi-Long Yi, Michael Barnett, Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies, Transfusion, 2009, 49, 11
  16. 16
    Elisabeth Maurer-Spurej, Audrey Labrie, Cheryl Pittendreigh, Kate Chipperfield, Clayton Smith, Nancy Heddle, Yang Liu, Qi-Long Yi, Michael Barnett, Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies, Transfusion, 2009, no

    CrossRef

  17. 17
    Jean Claude Osselaer, Chantal Doyen, Laurence Defoin, Cecile Debry, Maité Goffaux, Nathalie Messe, Maryse Van Hooydonk, Andre Bosly, Jin Sying Lin, Lily Lin, Laurence Corash, Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use, Transfusion, 2009, 49, 7
  18. 18
    N. M. Heddle, R. J. Cook, A. Tinmouth, C. T. Kouroukis, T. Hervig, E. Klapper, J. M. Brandwein, Z. M. Szczepiorkowski, J. P. AuBuchon, R. L. Barty, K.-A. Lee, A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia, Blood, 2008, 113, 7, 1564

    CrossRef

  19. 19
    M. A. Blajchman, S. J. Slichter, N. M. Heddle, M. F. Murphy, New Strategies for the Optimal Use of Platelet Transfusions, Hematology, 2008, 2008, 1, 198

    CrossRef

  20. 20
    N. M. Heddle, The value of evidence-based medicine, ISBT Science Series, 2008, 3, 1
  21. 21
    M. Lozano, J. Cid, Consensus and controversies in platelet transfusion: Trigger for indication, and platelet dose, Transfusion Clinique et Biologique, 2007, 14, 6, 504

    CrossRef

  22. 22
    N. M. Heddle, Controversy concerning platelet dose, ISBT Science Series, 2007, 2, 1
  23. 23
    S. J. Slichter, Evidence-Based Platelet Transfusion Guidelines, Hematology, 2007, 2007, 1, 172

    CrossRef

  24. 24
    Sherrill J. Slichter, Platelet Transfusion Therapy, Hematology/Oncology Clinics of North America, 2007, 21, 4, 697

    CrossRef

  25. 25
    Mark E. Brecher, The platelet prophylactic transfusion trigger: when expectations meet reality, Transfusion, 2007, 47, 2
  26. 26
    Araba Afenyi-Annan, Mark E. Brecher, Nicholas Bandarenko, Update on multi-center clinical trials in the United States, Transfusion and Apheresis Science, 2007, 36, 1, 5

    CrossRef

  27. 27
    David J. Kuter, Consultative Hemostasis and Thrombosis, 2007,

    CrossRef

  28. 28
    Lise Estcourt, Simon Stanworth, Carolyn Doree, Sally Hopewell, Michael F Murphy, Alan Tinmouth, Nancy Heddle, Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation, The Cochrane Library,